Sellas Life Sciences Group Inc (SLS)
Fair Value-45.7% Downside
Overvalued
Analyst170.4% Upside
Market Cap2.427 B
P/E—
Yield0.0%
HealthGood
NASDAQ
Tenax Therapeutics Inc (TENX)
Fair Value22.4% Upside
Undervalued
Analyst547.2% Upside
Market Cap111.1 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Vanda Pharmaceuticals Inc (VNDA)
Fair Value18.0% Upside
Undervalued
Analyst133.9% Upside
Market Cap315 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Vericel Corp Ord (VCEL)
Fair Value21.7% Upside
Undervalued
Analyst50.6% Upside
Market Cap2.06 B
P/E85.0x
Yield0.0%
HealthGreat
NASDAQ
Vertex Pharmaceuticals Inc (VRTX)
Fair Value-3.0% Downside
Fair
Analyst10.7% Upside
Market Cap130.5 B
P/E29.6x
Yield0.0%
HealthGreat
NASDAQ
Agios Pharm (AGIO)
Fair Value21.3% Upside
Undervalued
Analyst32.3% Upside
Market Cap2.088 B
P/E—
Yield0.0%
HealthGood
NASDAQ
Akari Therapeutics PLC (AKTX)
Fair Value33.7% Upside
Undervalued
Analyst153.7% Upside
Market Cap19.567 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Akebia Ther (AKBA)
Fair Value-2.3% Downside
Fair
Analyst299.7% Upside
Market Cap271.6 M
P/E—
Yield0.0%
HealthGood
NASDAQ
Aldeyra The (ALDX)
Fair Value-12.1% Downside
Fair
Analyst373.1% Upside
Market Cap84.155 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Amarin Corporation PLC (AMRN)
Fair Value8.3% Upside
Fair
Analyst-9.1% Downside
Market Cap290.4 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Anavex Life Sciences Corp (AVXL)
Fair Value13.2% Upside
Fair
Analyst709.7% Upside
Market Cap229 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Anixa Biosciences Inc (ANIX)
Fair Value-32.3% Downside
Overvalued
Analyst249.5% Upside
Market Cap96.991 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Arbutus Biopharma Corp (ABUS)
Fair Value5.9% Upside
Fair
Analyst8.4% Upside
Market Cap991.2 M
P/E6.5x
Yield0.0%
HealthExcellent
NASDAQ
Featured in
Financially Strong Value
High-Growth Small-Cap Stocks
Arcturus Therapeutics Holdings Inc (ARCT)
Fair Value-7.5% Downside
Fair
Analyst55.1% Upside
Market Cap408.7 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Ardelyx Inc (ARDX)
Fair Value12.6% Upside
Fair
Analyst255.4% Upside
Market Cap902.1 M
P/E—
Yield0.0%
HealthGood
NASDAQ
Atossa Therapeutics Inc (ATOS)
Fair Value13.7% Upside
Fair
Analyst726.0% Upside
Market Cap22.553 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Aurinia Pharmaceuticals Inc (AUPH)
Fair Value15.8% Upside
Fair
Analyst7.1% Upside
Market Cap2.218 B
P/E7.1x
Yield0.0%
HealthExcellent
NASDAQ
Featured in
Financially Strong Value
Avita Medical Ltd (RCEL)
Fair Value-27.6% Downside
Overvalued
Analyst7.1% Upside
Market Cap355.3 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Benitec Biopharma Ltd ADR (BNTC)
Fair Value-18.2% Downside
Overvalued
Analyst122.2% Upside
Market Cap382 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Capricor Therapeutics Inc (CAPR)
Fair Value17.1% Upside
Fair
Analyst189.1% Upside
Market Cap543 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Cardiff Oncology Inc (CRDF)
Fair Value-4.6% Downside
Fair
Analyst337.2% Upside
Market Cap103.5 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Featured in
Bullish Trend Stocks
Caredx Inc (CDNA)
Fair Value-27.3% Downside
Overvalued
Analyst-4.2% Downside
Market Cap2.922 B
P/E26.3x
Yield0.0%
HealthGreat
NASDAQ
Featured in
High-Momentum Stocks
Bullish Trend Stocks
Cellectar Biosciences Inc (CLRB)
Fair Value42.2% Upside
Undervalued
Analyst415.7% Upside
Market Cap21.078 M
P/E—
Yield0.0%
HealthFair
NASDAQ
CervoMed Inc (CRVO)
Fair Value6.8% Upside
Fair
Analyst508.7% Upside
Market Cap38.251 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Clinuvel Pharmaceuticals Ltd ADR (CUVL)
Fair Value55.1% Upside
Bargain
Market Cap296.1 M
P/E12.3x
Yield0.5%
HealthGreat
NASDAQ
Crescent Biopharma Inc (CBIO)
Fair Value-16.6% Downside
Fair
Analyst86.1% Upside
Market Cap703.6 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Dyadic International Inc (DYAI)
Fair Value41.1% Upside
Undervalued
Market Cap14.575 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Edesa Biotech Inc (EDSA)
Fair Value-15.2% Downside
Fair
Analyst301.3% Upside
Market Cap54.992 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Eledon Pharmaceuticals Inc (ELDN)
Fair Value-28.7% Downside
Overvalued
Analyst211.4% Upside
Market Cap235.1 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Enanta Pharmaceuticals Inc (ENTA)
Fair Value-15.3% Downside
Fair
Analyst75.8% Upside
Market Cap361.7 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Enlivex Therapeutics Ltd (ENLV)
Fair Value58.3% Upside
Bargain
Market Cap11.303 M
P/E—
Yield0.0%
HealthGood
NASDAQ
Ernexa Therapeutics Inc (ERNA)
Fair Value16.5% Upside
Fair
Analyst689.5% Upside
Market Cap6.203 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Evogene Ltd (EVGN)
Fair Value16.2% Upside
Fair
Analyst335.2% Upside
Market Cap7.618 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Exelixis Inc (EXEL)
Fair Value-31.0% Downside
Overvalued
Analyst-7.7% Downside
Market Cap14.409 B
P/E16.7x
Yield0.0%
HealthExcellent
NASDAQ
Fate Therapeutics Inc (FATE)
Fair Value-10.0% Downside
Fair
Analyst122.7% Upside
Market Cap309.1 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Galectin Therapeutics Inc (GALT)
Fair Value-50.1% Downside
Expensive
Analyst165.7% Upside
Market Cap417.5 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Genmab AS (GMAB)
Fair Value-24.7% Downside
Overvalued
Analyst11.1% Upside
Market Cap20.853 B
P/E26.5x
Yield0.0%
HealthGreat
NASDAQ
GeoVax Labs Inc (GOVX)
Fair Value17.2% Upside
Fair
Market Cap3.304 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
GT Biopharma Inc (GTBP)
Fair Value-8.9% Downside
Fair
Analyst944.6% Upside
Market Cap12.955 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Heron Therapeuti (HRTX)
Fair Value26.0% Upside
Undervalued
Analyst568.9% Upside
Market Cap56.766 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Ibio Inc (IBIO)
Fair Value0.2% Upside
Fair
Analyst327.7% Upside
Market Cap85.529 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Immunic Inc (IMUX)
Fair Value23.1% Upside
Undervalued
Analyst297.5% Upside
Market Cap147.9 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Immutep Ltd ADR (IMMP)
Fair Value62.3% Upside
Bargain
Analyst430.0% Upside
Market Cap43.005 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Inovio Pharmaceuticals Inc (INO)
Fair Value-11.7% Downside
Fair
Analyst145.5% Upside
Market Cap133.4 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Iovance Biotherapeutics Inc (IOVA)
Fair Value-12.5% Downside
Fair
Analyst-3.9% Downside
Market Cap4.82 B
P/E—
Yield0.0%
HealthGreat
NASDAQ
Featured in
High-Momentum Stocks
Bullish Trend Stocks
Kamada Ltd (KMDA)
Fair Value12.8% Upside
Fair
Analyst52.2% Upside
Market Cap504.6 M
P/E22.7x
Yield1.9%
HealthGreat
NASDAQ
Karyopharm Therapeutics Inc (KPTI)
Fair Value2.3% Upside
Fair
Analyst298.4% Upside
Market Cap41.28 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Larimar Therapeutics Inc (LRMR)
Fair Value18.6% Upside
Undervalued
Analyst277.0% Upside
Market Cap398.7 M
P/E—
Yield0.0%
HealthWeak
NASDAQ